| Biologic Therapy |
0 |
0.63 |
| Acute Leukemia |
0 |
0.95 |
| Child |
0 |
0.99 |
| CAR-T |
0 |
0.48 |
| Bone Marrow Transplant |
0 |
0.41 |
| Toxicology |
0 |
0.37 |
| Stem Cell Research and Therapy |
0 |
0.35 |
| T-Lymphocyte |
0 |
0.33 |
| Bone Marrow |
0 |
0.31 |
| Blood |
0 |
0.27 |
| Immunotherapy |
0 |
0.27 |
| Genomic Medicine |
0 |
0.23 |
| Bone |
0 |
0.22 |
| Cancer |
0 |
0.22 |
| Face |
0 |
0.22 |
| Hematology |
0 |
0.22 |
| Hospital |
0 |
0.22 |
| Refractory |
0 |
0.22 |
| Transplantation |
0 |
0.22 |
| Acute Lymphoblastic Leukemia |
0 |
1 |
| Leukemia |
0 |
0.17 |
| Remission |
0 |
0.17 |
| Clinical Research |
0 |
0.11 |
| Massachusetts |
0 |
0.11 |
| Medical Life |
0 |
0.07 |
| Antigens |
0 |
0.06 |
| Board Certification |
0 |
0.06 |
| Brachial |
0 |
0.06 |
| Chemotherapy |
0 |
0.06 |
| Clinician Health and Well-Being |
0 |
0.06 |
| Colorado |
0 |
0.06 |
| Genetics |
0 |
0.06 |
| Prognosis |
0 |
0.06 |
| Receptors |
0 |
0.06 |
| Young Adult |
0 |
0.9 |